Basket Trials Evaluating Tazemetostat Combinations for Multiple New Heme and Solid Tumor Cancers to be Initiated in Second Half 2021 “The recent accelerated approvals of TAZVERIK in Epithelioid ...
AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set to transform ...
Cash, cash equivalents and marketable securities expected to support operations into the third quarter of 2027 WATERTOWN, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NMRA), a ...
Conduit Pharmaceuticals has made significant advancements in its pipeline, particularly in preclinical studies for its drug AZD5658 and the design of a Phase IIa clinical trial for AZD1656, targeting ...
For life sciences companies, the innovation pipeline is the business. As therapies grow more complex—spanning biologics, cell and gene therapies, platforms, combination products, and AI-enabled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results